National Institutes of Health

Description

The purpose of this funding opportunity announcement (FOA) is to stimulate the formation of centers that will conduct cutting-edge research studies designed to push the boundaries for understanding and predicting therapeutic drug responses. The FOA describes research centers that examine drug actions within the context of precision medicine, or data-driven prescribing. This program will support a limited number of large-scale multidisciplinary centers, each of which will serve as a national and international focal point. A center should be built around a tightly-focused theme and should represent innovative investigations at the forefront of understanding drug actions. The experimental approaches should go beyond pharmacogenomics, to include for example, examination of gene expression and regulation patterns, assessment of post-genomic modifications, other small-molecule signatures that contribute to the prediction of drug actions both therapeutic and adverse, and/or systems and pathway analysis.

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education
• For-profit organizations other than small businesses
• Small businesses
• Others

Contact

NIH OER Webmaster <br/>FBOWebmaster@OD.NIH.GOV <br/>
FBOWebmaster@OD.NIH.GOV